| Share on Facebook Facebook | Share on StumbleUpon StumbleUpon |
| Share on LinkedIn LinkedIn | Submit on Reddit reddit |
| Tweet Twitter | Pin it Pinterest |
| Share on Google+ Google+ | Share on Digg Digg |
| Post to Tumblr Tumblr | Share on Delicious Delicious |
-
VanEck Blog - Moat Investing
Moat InvestingNovember 06, 2020
Moat Stocks: Poised for a Comeback?
by Brandon Rakszawski, Senior ETF Product Manager
The Morningstar Wide Moat Focus Index has historically posted excess returns in periods following months of underperformance, according to Morningstar. Will that hold true following this summer's slump?
Moat InvestingOctober 08, 2020
Can Wells Fargo, Boeing and Biogen Add Value?
by Brandon Rakszawski, Senior ETF Product Manager
Read moreAs active managers continue to underperform U.S. equity benchmarks, we look at the importance of moats and valuations to the Morningstar® Wide Moat Focus IndexSM ’s performance and highlight its most undervalued constituents.
Moat InvestingSeptember 23, 2020
Moat Index Review: Value Is In, Facebook Is Out
by Brandon Rakszawski, Senior ETF Product Manager
Read moreThe latest quarterly review of the Morningstar Wide Moat Focus Index continues the key trends of the year: the shift away from big tech, tech and health care sector weight increases and an all-time high in value exposure.
Moat InvestingSeptember 08, 2020
Focusing on Valuations in a Distorted Market
by Brandon Rakszawski, Senior ETF Product Manager
Read moreThe S&P 500 Index is positive for the year so far, despite more than half of its constituents posting negative total returns. Are certain sectors becoming far too overvalued?
Moat InvestingAugust 07, 2020
Innovation Fortifies Drug Company Moats
by Brandon Rakszawski, Senior ETF Product Manager
Read moreThe long standing healthcare overweight in the Morningstar Wide Moat Focus Index goes beyond patent protection to include the ability of large pharmaceutical and biotech companies to innovate.